Monteverde & Associates Initiates Investigations into Multiple M&A Deals
New York-based law firm Monteverde & Associates is investigating potential breaches of fiduciary duty regarding four separate corporate transactions.
Monteverde & Associates PC has launched investigations into the acquisition terms of four publicly traded companies: Lifecore Biomedical, Inc., Lisata Therapeutics, Inc., Flag Ship Acquisition Corporation, and The Baldwin Insurance Group, Inc. The firm is examining whether the proposed transaction terms adequately protect shareholder value.
For Lifecore Biomedical, the firm is reviewing the sale to affiliates of Webster Equity Partners, which includes a cash payment of $6.28 per share alongside potential contingent value rights tied to performance milestones through 2030. Simultaneously, the firm is analyzing the sale of The Baldwin Insurance Group to Sequence AI Holdings at $32.50 per share.
The firm is inviting shareholders of these companies to reach out for a legal review of the proposed mergers and acquisitions. These investigations are standard procedure for shareholder rights firms, aiming to determine if directors fulfilled their obligations to shareholders during the sale or merger process.